Table 2 Findings related to changes in intake of energy, and macronutrients at the beginning and end of the study.
Variables | Time | Placebo | Groups | ||
|---|---|---|---|---|---|
I1* | I2# | Pvalue | |||
Mean ± SD | Mean ± SD | Mean ± SD | |||
Energy (Kcal) | Baseline | 2052.83 ± 306.74 | 2068.92 ± 227.10 | 2159.69 ± 173.15 | 0.97 |
12-Weeks | 1993.48 ± 278.61 | 2095 ± 210.05 | 2183.36 ± 147.24 | ||
Protein (gr) | Baseline | 72.48 ± 7.10 | 71.79 ± 9.39 | 83.39 ± 10.93 | |
12-Weeks | 69.81 ± 9.19 | 71.99 ± 7.24 | 82.13 ± 10.36 | 0.63 | |
Fat (gr) | Baseline | 70.36 ± 11.06 | 65.30 ± 6.70 | 78.02 ± 10.96 | |
12-Weeks | 68.43 ± 7.11 | 63.30 ± 8.63 | 76.32 ± 7.87 | 0.92 | |
Carbohydrate (gr) | Baseline | 301.86 ± 55.83 | 302.21 ± 41.49 | 384.94 ± 20.26 | |
12-Weeks | 298.75 ± 53.30 | 306.13 ± 39.90 | 389.08 ± 24.05 | 0.99 | |
PUFA (gr) | Baseline | 12.52 ± 3.59 | 11.20 ± 1.39 | 13.37 ± 3.88 | 0.85 |
12-Weeks | 12.14 ± 2.47 | 11.03 ± 1.93 | 13.39 ± 3.07 | ||
MUFA (gr) | Baseline | 20.88 ± 4.05 | 19.09 ± 1.82 | 23.35 ± 3.70 | 0.46 |
12-Weeks | 19.10 ± 2.28 | 18.32 ± 3.02 | 22.47 ± 3.00 | ||
SFA (gr) | Baseline | 19.95 ± 4.16 | 19.05 ± 2.56 | 24.77 ± 4.57 | 0.59 |
12-Weeks | 18.44 ± 2.49 | 18.34 ± 3.40 | 23.97 ± 3.92 | ||
Cholesterol (mg) | Baseline | 279.93 ± 45.28 | 263.86 ± 58.23 | 325.86 ± 55.65 | 0.34 |
12-Weeks | 261.52 ± 59.24 | 280.78 ± 56.33 | 322.95 ± 47.25 | ||
